<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="EN" hierarchy="1" humanitarian="1" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>GB-GOV-13-FUND--Newton-MR_T018089_1</iati-identifier>
  <reporting-org ref="10" type="DEPARTMENT OF BUSINESS, ENERGY AND INDUSTRIAL STRATEGY">
   <narrative xml:lang="EN">1</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Genomic profiling of Cardiomyopathy in Malaysia</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">2</narrative>
  </description>
  <description type="1">
   <narrative xml:lang="EN">Inherited cardiomyopathy is one of the most common causes of heart failure. The most common forms are  Hypertrophic Cardiomyopathy or HCM, which affects 1 in 500 of the population, and dilated cardiomyopathy or DCM, which affects 1 in 2500. Individuals with cardiomyopathy may not be aware of the condition until they develop complications.  To date, there is no cure for these diseases and patients are mainly treated symptomatically. Most of systematic genetic studies of HCM and DCM have focused on North American or Western European patient populations. This planned work will extend initial findings that some predominant mutations reported in Caucasians are absent in the Malaysian population and provide a comprehensive analysis of the genetic profiles of Malaysian cardiomyopathy patients. We hope the study will identify significant variants in the Malaysian population and provide valuable information to improve the clinical aspects of cardiomyopathy, including early diagnosis, prognosis and genetic counselling for affected families, in Malaysia. Overall, it will lead to improvement of the welfare of the population of Malaysia by improving the diagnosis and clinical management of cardiomyopathy in Malaysia with lasting benefits for patients and their families.</narrative>
  </description>
  <other-identifier type="GB-GOV-13"></other-identifier>
  <activity-status code="2019-12-01"></activity-status>
  <activity-date iso-date="2019-12-31" type="2"></activity-date>
  <activity-date iso-date="2021-11-30" type="3"></activity-date>
  <activity-date iso-date="MY" type="MALAYSIA"></activity-date>
  <activity-date type="4"></activity-date>
  <contact-info type="UK RESEARCH &amp; INNOVATION">
   <organisation>
    <narrative xml:lang="EN">International Development</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Newton</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">gcrf@ukri.org</narrative>
   </person-name>
   <email>https://www.ukri.org/</email>
   <website>Polaris House, Swindon, SN2 1LF</website>
   <mailing-address>
    <narrative xml:lang="EN">GBP</narrative>
   </mailing-address>
  </contact-info>
  <recipient-country code="FAR EAST ASIA, REGIONAL" percentage="100">
   <narrative xml:lang="EN">789</narrative>
  </recipient-country>
  <recipient-region code="1" percentage="100" vocabulary="RESEARCH/SCIENTIFIC INSTITUTIONS"></recipient-region>
  <sector percentage="100" vocabulary="1">
   <narrative xml:lang="EN">43082</narrative>
  </sector>
  <collaboration-type code="10"></collaboration-type>
  <default-flow-type code="110"></default-flow-type>
  <default-finance-type code="D02"></default-finance-type>
  <default-aid-type code="5" vocabulary="1"></default-aid-type>
  <budget status="2" type="1">
   <period-start iso-date="2019-04-01"></period-start>
   <period-end iso-date="2019-03-31"></period-end>
   <value currency="GBP" value-date="2019-11-26">19888.22</value>
  </budget>
  <budget status="2" type="1">
   <period-start iso-date="2020-04-01"></period-start>
   <period-end iso-date="2020-03-31"></period-end>
   <value currency="GBP" value-date="2019-11-26">79713.97</value>
  </budget>
  <budget status="2" type="1">
   <period-start iso-date="2021-04-01"></period-start>
   <period-end iso-date="2021-03-31"></period-end>
   <value currency="GBP" value-date="2019-11-26">60147.93</value>
  </budget>
  <capital-spend percentage="1) To investigate genetic variations in cardiomyopathy patients in Malaysia via a whole-genome sequencing approach. 2) To relate the gene variants to the development of cardiomyopathy in Malaysian patients. 3) To associate the gene variants with the clinical spectrum of cardiomyopathy in the Malaysian cohort. 4) To determine, via in silico and/or in vitro approaches, the impacts of the mutations on protein-structure function and cardiomyocyte contractility."></capital-spend>
  <document-link format="HTTPS://WWW.UKRI.ORG/FUNDING/INFORMATION-FOR-AWARD-HOLDERS/GRANT-TERMS-AND-CONDITIONS/" url="A04">
   <title>
    <narrative xml:lang="EN">application/pdf</narrative>
   </title>
   <category code="0"></category>
  </document-link>
  <conditions attached="UK Research &amp; Innovation Grant Terms and Conditions"></conditions>
  <iati-activities>
   <iati-activity>
    <title>
     <narrative xml:lang="2021-09-24"></narrative>
    </title>
   </iati-activity>
  </iati-activities>
 </iati-activity>
</iati-activities>
